跳至主要内容
临床试验/NCT01276691
NCT01276691已完成4 期

Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting

University of Illinois at Urbana-Champaign1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2011年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
24
试验地点
1
主要终点
Inflammatory and Oxidative Stress markers

研究概览

简要总结

The investigators hypothesize that

  1. an acute treatment of low-dose aspirin will lead to a) decreased resting platelet activation, platelet aggregation, and clotting potential, b) increased fibrinolytic potential following fire fighting, c) no significant effect on endothelial function or arterial stiffness versus the placebo condition.
  2. chronic treatment with low-dose aspirin will lead to a) decreased resting and fire fighting induced platelet activation, platelet aggregation, clotting potential, b) increased fibrinolytic potential, and c) increased endothelial function and decreased arterial stiffness in response to live fire fighting versus the placebo condition.
  3. short-term fire fighting activity will result in: a) a reduction in arterial function (reduced endothelial function, increased augmentation index and an attenuated arterial stiffness response); b) a disruption in hemostasis that is characterized by an increase in platelet number and function, an increased coagulatory potential and altered fibrinolytic potential; and c) an elevation in procoagulatory cytokines, systemic inflammation, monokine chemoattractant protein, and matrix metalloproteinases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Male firefighters (career and volunteer), medically cleared by home fire department.
  • •Ages 40 - 60
  • •Completion of a yearly period medical evaluation based on NFPA 1582 within the past 12 months or an evaluation by an occupational medical group through this study.

排除标准

  • •Over 60 or under 40 years of age.
  • •Not a firefighter.
  • •Individuals at risk for developing gastrointestinal (GI) complications while on aspirin therapy due to a combination of the following: smoking; concurrent NSAID, steroid, Clopidogrel, or Warfarin therapy; history of upper GI complications; history of renal impairment; history of elevated serum creatinine; hypertension; and cardiac failure.
  • •Individuals with cases of allergy or asthma, intolerance, and recurrent vascular events.
  • •Individuals taking statins.
  • •Individuals who are currently taking aspiring regularly.

研究组 & 干预措施

Chronic, Aspirin

Active Comparator

81 mg asprin provided prior to firefighting- 14 day dosage

干预措施: 81 mg enteric coated aspirin (Drug)

Acute, Aspirin

Active Comparator

81 mg asprin provided 30 minutes prior to firefighting- Acute single dosage

干预措施: 81 mg enteric coated aspirin (Drug)

Acute, Placebo

Placebo Comparator

Acute single dosage of placebo provided 30 minutes prior to firefighting

干预措施: 81 mg enteric coated aspirin (Drug)

Chronic, Placebo

Placebo Comparator

14 day dosage of placebo provided prior to firefighting

干预措施: 81 mg enteric coated aspirin (Drug)

结局指标

主要结局

Inflammatory and Oxidative Stress markers

时间窗: Less than 60 minutes after completing 20 minutes of firefighting activity

CRP,Intercellular adhesion molecule (ICAM)-1, IL-6, MMP-9, TIMP-1, TIMP-2,8-iso-prostaglandin F2a, soluble P-selectin

Hemostatic balance

时间窗: Less than 60 minutes after completing 20 minutes of firefighting activity

Blood samples will be collected by a trained phlebotomist from the antecubital vein directly into vacutainers with little or no stasis using a 21-gauge needle. Samples will be used to quantify platetlet number and function, fibrinogen, prothrombin and partial thromboplastin time, t-PA and PAI-1 activities and antigen

Vascular function

时间窗: Less than 60 minutes after completing 20 minutes of firefighting activity

Vascular function will be assessed via pulse wave analysis, pulse wave velocity, carotid artery compliance, beta stiffness index, forearm rsistance artery vasodilatory capacity, and brachial artery blood flow.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gavin Horn

Senior Research Scientist

University of Illinois at Urbana-Champaign

研究点 (1)

Loading locations...

相似试验